Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
5.46
-0.17 (-3.02%)
Apr 29, 2026, 10:48 AM EDT - Market open
Polaryx Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 5.14 | 4.62 | 0 |
| Cash & Short-Term Investments | 5.14 | 4.62 | 0 |
| Cash Growth | 11.30% | 230950.00% | - |
| Prepaid Expenses | - | 0.38 | 2.31 |
| Other Current Assets | 0.03 | - | - |
| Total Current Assets | 5.17 | 5 | 2.32 |
| Accounts Payable | 0.47 | 0.07 | 0.47 |
| Accrued Expenses | 0.14 | 0.22 | 0.44 |
| Short-Term Debt | - | - | 0.13 |
| Total Current Liabilities | 0.61 | 0.29 | 1.04 |
| Common Stock | 0.01 | 0 | 0 |
| Additional Paid-In Capital | 104.2 | 95.36 | 61.57 |
| Retained Earnings | -99.64 | -90.65 | -60.29 |
| Total Liabilities & Equity | 5.17 | 5 | 2.32 |
| Total Debt | - | - | 0.13 |
| Net Cash (Debt) | 5.14 | 4.62 | -0.13 |
| Net Cash Growth | 11.30% | - | - |
| Net Cash Per Share | 0.11 | 0.14 | -0.01 |
| Filing Date Shares Outstanding | 47.34 | 41.15 | 10.69 |
| Total Common Shares Outstanding | 47.34 | 41.15 | 10.69 |
| Working Capital | 4.57 | 4.71 | 1.28 |
| Book Value Per Share | 0.10 | 0.11 | 0.12 |
| Tangible Book Value | 4.57 | 4.71 | 1.28 |
| Tangible Book Value Per Share | 0.10 | 0.11 | 0.12 |
Source: S&P Capital IQ. Standard template.
Financial Sources.